Home › Funds › Rock Springs Capital Management LP › KYMR

Rock Springs Capital Management LP position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Rock Springs Capital Management LP reported holding 409,631 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$45.8M, representing 2.48% of its reported portfolio and ranking #7 among its reported holdings. Rock Springs Capital Management LP has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)409.63K sh
Reported value held$45.79M
Portfolio Weight2.48%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's KYMR position evolved

Rock Springs Capital Management LP first disclosed a stake in KYMR in Q3 2023 at 1,504,351 shares (US$20.9M). The position peaked in Q1 2024 at 1,522,238 shares, worth US$61.2M. Across 13 filings, Rock Springs Capital Management LP increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 409,631 shares valued at US$45.8M — a reduction of -43,525 shares quarter over quarter.. Notable position changes include a 43% trim in Q2 2025 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.50M $20.91M New
Q4 2023 1.52M $38.76M Add
Q1 2024 1.52M $61.19M Hold
Q2 2024 1.16M $34.74M Reduce
Q3 2024 1.05M $49.67M Reduce
Q4 2024 1.03M $41.60M Reduce
Q1 2025 794.44K $21.74M Reduce
Q2 2025 450.37K $19.65M Reduce
Q3 2025 450.37K $25.49M Hold
Q4 2025 496.87K $38.66M Add
Q1 2026 496.87K $41.38M Hold
Q2 2026 453.16K $51.96M Reduce
Q3 2026 409.63K $45.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$835.6M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Rock Springs Capital Management LP held KYMR?

Rock Springs Capital Management LP has disclosed KYMR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in KYMR?

As of Q3 2026, Rock Springs Capital Management LP holds 409.63K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $45.79M, representing 2.48% of its reported portfolio and ranking #7.

Has Rock Springs Capital Management LP been buying or selling KYMR?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in KYMR. The position peaked in Q1 2024 at 1.52M shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.